profit from every $100 of sales.
$0$100
Orthofix Medical
$6.94-3.34% today
-54.6% in 1 year
1-year low $6.941-year high $16.20
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Orthofix Medical sold, what it kept, and what it did with the cash.
Sales went from $461 million in 2022 to $822 million in 2025, with -$92.2 million of profit last year.
SalesProfit
Orthofix Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Orthofix Medical | No profit yet | ||
 Boston Scientific | 22.1× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.5× · Expensive | ||
 Zimmer Biomet Holdings | 28.1× · Fair price |
AI analysis
An AI analyst reads Orthofix Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 461 | 747 | 799 | 822 | |
| 337 | 486 | 546 | 566 | |
| -29 | -142 | -78 | -83 | |
| 16 | -79 | -18 | 10 | |
| -20 | -151 | -126 | -92 | |
| -0.98 | -4.12 | -3.30 | -2.33 | |
| 73.2% | 65.1% | 68.3% | 68.8% | |
| -6.3% | -19.0% | -9.7% | -10.0% | |
| -4.3% | -20.3% | -15.8% | -11.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 459 | 925 | 893 | 851 |
| Cash | 51 | 33 | 83 | 82 |
| Total debt | 22 | 117 | 180 | 178 |
| Total liabilities | 122 | 327 | 390 | 401 |
| 337 | 599 | 503 | 450 | |
| 20 | 37 | 38 | 40 | |
| -3.6% | -15.5% | -10.9% | -9.2% | |
| -5.9% | -25.3% | -25.0% | -20.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -12 | -46 | 26 | 33 | |
| 23 | 62 | 35 | 35 | |
| -35 | -108 | -9 | -1 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 18 | 36 | 32 | 29 |
Valuation
- –
- –
- –
- 1.0×
- 0.3×
- –
- 38.2×
- -0.5%
- -32.6%
- 0.0%
Profitability
- 68.8%
- -10.0%
- -11.2%
- 11.6%
- -4.6%
- -13.9%
- -13.4%
- -6.8%
- -4.6%
- 7.4%
Growth
- +21.3%
- –
- +85.9%
- –
- +19.3%
Financial health
- 1.2×
- 0.54
- 26.4%
- -1.8×
- 2.87
- 1.76
- 0.93
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 30%of 952
Bottom 15%of 883
Top 27%of 870
Bottom 37%of 985
What analysts expect
- Average price target
- $18.00
- Range
- $18.00 – $18.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | -0.52 | -0.68 | +23.5% |
| Feb 24, 2026 | -0.06 | -0.19 | +70.8% |
| Nov 4, 2025 | 0.20 | 0.12 | +66.7% |
| Aug 5, 2025 | 0.13 | 0.04 | +225.0% |
| May 6, 2025 | -0.08 | -0.17 | +52.9% |
| Feb 25, 2025 | 0.02 | 0.06 | −66.7% |
| Nov 7, 2024 | 0.07 | -0.14 | +150.0% |
| Aug 6, 2024 | 0.05 | -0.13 | +138.5% |
News
Orthofix Medical Inc. Q3 2026 Earnings Call SummaryYahoo Finance · Nov 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
62Pass
Philip Fisher
42No pass
Peter Lynch
60Pass
Joel Greenblatt
0No pass
Charlie Munger
25No pass
Terry Smith
28No pass
Questions about Orthofix Medical
Is Orthofix Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Orthofix Medical AI analysis
What does Orthofix Medical do?
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. It is in Medical - Devices.
Does Orthofix Medical pay a dividend?
No. Orthofix Medical does not pay a dividend at the moment.
Is Orthofix Medical stock halal?
No. Orthofix Medical does not pass our halal screen: its debt is 63% of its market value, at or above the 33% limit. How we check
How has Orthofix Medical stock done over the past year?
Down 54.6% over the past twelve months, to $6.94. It traded between $6.94 and $16.20 and is 57.2% below its high.
Who are Orthofix Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Orthofix Medical's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.